A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder
- 29 April 2023
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 73, 65-74
Abstract
No abstract availableKeywords
Funding Information
- Stanley Medical Research Institute
This publication has 26 references indexed in Scilit:
- Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophreniaSchizophrenia Research, 2012
- 14:45 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN SCHIZOPHRENIA: READY FOR PRACTICE OR A GOOD START? A META-ANALYSISSchizophrenia Research, 2012
- 3-Hydroxy-3-methylglutaryl–Coenzyme A Reductase Inhibitors in the Treatment of Central Nervous System DiseasesArchives of Neurology, 2010
- Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum DisordersThe Journal of Clinical Psychiatry, 2010
- Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)Schizophrenia Research, 2008
- COX-2 Inhibitors as Adjunctive Therapy in SchizophreniaCNS Drugs, 2005
- Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in SchizophreniaAmerican Journal of Psychiatry, 2002
- The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor AnalysisThe Journal of Clinical Psychiatry, 2001
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970